A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
Recruiting
Phase 1
Interventional Study
Healthy Adult Male and Female Volunteers
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 212 (estimated)
- Sponsor
- Centessa Pharmaceuticals (UK) Limited · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Characterize the safety, tolerability and pharmacokinetics of ORX489 following single and multiple doses.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Healthy males or females as determined by assessments at the Screening Visit.
* For Parts A, B, C, and D: Participants must be at least 18 years of age and no more than 60 years of age at the Screening
Exclusion Criteria:
* Presence of significant cardiac, pulmonary, gastroi…
Contacts
ORX489 Centessa Program Lead ORX489 Centessa Program Lead
617-468-5770
CONTACT
Celerion Program Lead CA49982 United States, Nebraska [Recruiting]
CONTACT